Treatment of hypersensivity reactions and anaphylactic shock occurring during anaesthesia;Traitement des réactions anaphylactiques survenant en cours d'anesthésie et en particulier du choc anaphylactique

Annales Francaises d'Anesthesie et de Reanimation

Volumn 30, Issue 3, 2011, Pages 312-322

  Longrois, D ^a   Lejus, C ^b   Constant, I ^c   Bruyere M ^d   Mertes, P M ^e  

^a BICHAT HOSPITAL   (France)

^b HÔTEL DIEU   (France)

^c ARMAND TROUSSEAU HOSPITAL   (France)

^d BICÊTRE HOSPITAL   (France)

^e INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPHYLACTIC SHOCK; ANESTHESIA COMPLICATION; ANESTHESIA INDUCTION; ARTICLE; HYPERSENSITIVITY REACTION; TREATMENT PLANNING;

AFTERCARE; AIRWAY OBSTRUCTION; ANAPHYLAXIS; ANESTHESIA; ANESTHETICS, GENERAL; CARDIOVASCULAR DISEASES; COMBINED MODALITY THERAPY; DISEASE MANAGEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG HYPERSENSITIVITY; EPINEPHRINE; GLUCOCORTICOIDS; HISTAMINE ANTAGONISTS; HUMANS; INTRAOPERATIVE COMPLICATIONS; PLASMA SUBSTITUTES; RESPIRATION, ARTIFICIAL; RISK ASSESSMENT; VASOCONSTRICTOR AGENTS;

EID: 79953154065     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2010.12.010     Document Type: Article

References (55)

1. Soar J., Pumphrey R., Cant A., Clarke S., Corbett A., Dawson P., et al. Emergency treatment of anaphylactic reactions - guidelines for healthcare providers. Resuscitation 2008, 77:157-169.
2. Lieberman P. Anaphylactic reactions during surgical and medical procedures. J Allergy Clin Immunol 2002;110(Suppl. 2):S64-9.
3. Pumphrey R.S. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000, 30:1144-1150.
4. Pumphrey R.S., Roberts I.S. Postmortem findings after fatal anaphylactic reactions. J Clin Pathol 2000, 53:273-276.
5. Currie M., Kerridge R.K., Bacon A.K., Williamson J.A. Crisis management during anaesthesia: anaphylaxis and allergy. Qual Saf Health Care 2005, 14:e19.
6. Ellis A.K., Day J.H. Diagnosis and management of anaphylaxis. CMAJ 2003, 19(169):307-311.
7. Hepner D.L., Castells M.C. Anaphylaxis during the perioperative period. Anesth Analg 2003, 97:1381-1395.
8. Whittington T. Anaphylactic anaphylactoid reactions. Baillieres Clin Anaesthesiol 1998, 12:301-323.
9. Currie M., Webb R.K., Williamson J.A., Russell W.J., Mackay P. Clinical anaphylaxis: an analysis of 2000 incident reports. Anaesth Intensive Care 1993, 21:621-625. The Australian Incident Monitoring Study.
10. Laxenaire M.C. Épidémiologie des réactions anaphylactoïdes peranesthésiques. Quatrième enquête multicentrique (juillet 1994-décembre 1996). Ann Fr Anesth Reanim 1999, 18:796-809. Groupe d'études des réactions anaphylactoïdes peranesthésiques.
11. Fox A.J., McLaren I.M., Naylor A.R. Cerebral perfusion monitored using transcranial Doppler during acute anaphylaxis. Anaesthesia 1999, 54:678-682.
12. Robertson C.E. Advanced life support guidelines. European Resuscitation Council. Br J Anaesth 1997, 79:172-177.
13. Cummins R.O., Sanders A., Mancini E., Hazinski M.F. In-hospital resuscitation: a statement for healthcare professionals from the American Heart Association Emergency Cardiac Care Committee and the Advanced Cardiac Life Support, Basic Life Support, Pediatric Resuscitation, and Program Administration Subcommittees. Circulation 1997, 95:2211-2212.
14. Kloeck W., Cummins R.O., Chamberlain D., Bossaert L., Callanan V., Carli P., et al. Special resuscitation situations: an advisory statement from the International Liaison Committee on Resuscitation. Circulation 1997, 95:2196-2210.
15. Dewachter P., Raeth-Fries I., Jouan-Hureaux V., Menu P., Vigneron C., Longrois D., et al. A comparison of epinephrine only, arginine vasopressin only, and epinephrine followed by arginine vasopressin on the survival rate in a rat model of anaphylactic shock. Anesthesiology 2007, 106:977-983.
16. Dewachter P., Jouan-Hureaux V., Lartaud I., Bello G., de Talance N., Longrois D., et al. Comparison of arginine vasopressin, terlipressin, or epinephrine to correct hypotension in a model of anaphylactic shock in anesthetized brown Norway rats. Anesthesiology 2006, 104:734-741.
17. Kloeck W., Cummins R.O., Chamberlain D., Bossaert L., Callanan V., Carli P., et al. The universal advanced life support algorithm: an advisory statement from the Advanced Life Support Working Group of the International Liaison Committee on Resuscitation. Circulation 1997, 95:2180-2182.
18. Longrois D. Monitorage de la profondeur de l'anesthésie. In: Sfar, editeur. Congrès national d'anesthésie et de réanimation. Conférences d'actualisation. Paris: Elsevier; 2008. p. 25-46.
19. Laxenaire MC, Moneret-Vautrin DA, Guéant JL. Réactions allergiques au cours de l'anesthésie. In: Sfar, editeur. Congrès national d'anesthésie et de réanimation. Conférences d'actualisation. Paris: Elsevier; 1996. p. 229-44.
20. Dewachter P., Mouton-Faivre C., Nace L., Longrois D., Mertes P.M. Treatment of anaphylactic reaction in prehospital and in the emergency room: literature review. Ann Fr Anesth Reanim 2007, 26:218-228.
21. Heytman M., Rainbird A. Use of alpha-agonists for management of anaphylaxis occurring under anaesthesia: case studies and review. Anaesthesia 2004, 59:1210-1215.
22. Kluger M.T. The bispectral index during an anaphylactic circulatory arrest. Anaesth Intensive Care 2001, 29:544-547.
23. Levy J.H., Adkinson N.F. Anaphylaxis during cardiac surgery: implications for clinicians. Anesth Analg 2008, 106:392-403.
24. Nurmatov U., Worth A., Sheikh A. Anaphylaxis management plans for the acute and long-term management of anaphylaxis: a systematic review. J Allergy Clin Immunol 2008, 122:353-361.
25. Simons F.E. Emergency treatment of anaphylaxis. BMJ 2008, 336:1141-1142.
26. Brener Z.Z., Zhuravenko I., Bergman M. Acute myocardial injury following penicillin-associated anaphylactic reaction in a patient with normal coronary arteries. Am J Med Sci 2007, 334:305-307.
27. Kemp S.F., Lockey R.F., Simons F.E. Epinephrine: the drug of choice for anaphylaxis. A statement of the World Allergy Organization. Allergy 2008, 63:1061-1070.
28. Schummer C., Wirsing M., Schummer W. The pivotal role of vasopressin in refractory anaphylactic shock. Anesth Analg 2008, 107:620-624.
29. Klein J.S., Yunginger J.W., Rich M. Myocardial dysfunction after epinephrine treatment of presumed insect venom allergy in a marathon runner. Ann Allergy Asthma Immunol 2008, 100:285-286.
30. Fugner A. Inhibition of antigen-induced histamine release by beta-adrenergic stimulants in vivo. Int Arch Allergy Appl Immunol 1977, 54:78-87.
31. Green R., Ball A. Alpha-agonists for the treatment of anaphylactic shock. Anaesthesia 2005, 60:621-622.
32. Gandhi R., Sharma B., Sood J. Severe anaphylaxis during general anaesthesia in a beta-blocked cardiac patient: considerations. Acta Anaesthesiol Scand 2008, 52:574.
33. Goddet N.S., Descatha A., Liberge O., Dolveck F., Boutet J., Baer M., et al. Paradoxical reaction to epinephrine induced by beta-blockers in an anaphylactic shock induced by penicillin. Eur J Emerg Med 2006, 13:358-360.
34. Bautista E., Simons F.E., Simons K.J., Becker A.B., Duke K., Tillett M., et al. Epinephrine fails to hasten hemodynamic recovery in fully developed canine anaphylactic shock. Int Arch Allergy Immunol 2002, 128:151-164.
35. Rocq N., Favier J.C., Plancade D., Steiner T., Mertes P.M. Successful use of terlipressin in post-cardiac arrest resuscitation after an epinephrine-resistant anaphylactic shock to suxamethonium. Anesthesiology 2007, 107:166-167.
36. Kam P.C., Williams S., Yoong F.F. Vasopressin and terlipressin: pharmacology and its clinical relevance. Anaesthesia 2004, 59:993-1001.
37. American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2005;112(Suppl. 24):IV1-203.
38. Schierhout G., Roberts I. Fluid resuscitation with colloid or cristalloid solutions in critically ill patients: a systematic review of randomised trials. Br Med J 1998, 316:961-964.
39. Bickell W.H., Dice W.H. Military antishock trousers in a patient with adrenergic-resistant anaphylaxis. Ann Emerg Med 1984, 13:189-190.
40. Granata A.V., Halickman J.F., Borak J. Utility of military anti-shock trousers (MAST) in anaphylactic shock - a case report. J Emerg Med 1985, 2:349-351.
41. Jacobs R.L., Rake G.W., Fournier D.C., Chilton R.J., Culver W.G., Beckmann C.H. Potentiated anaphylaxis in patients with drug-induced beta-adrenergic blockade. J Allergy Clin Immunol 1981, 68:125-127.
42. McKinnon R.P., Sinclair C.J. Angiotensinamide in the treatment of probable anaphylaxis to succinylated gelatin (Gelofusine). Anaesthesia 1994, 49:309-311.
43. Evora P.R. Should methylene blue be the drug of choice to treat vasoplegias caused by cardiopulmonary bypass and anaphylactic shock?. J Thorac Cardiovasc Surg 2000, 119:632-634.
44. Bellou A., Lambert H., Gillois P., Montemont C., Gerard P., Vauthier E., et al. Constitutive nitric oxide synthase inhibition combined with histamine and serotonin receptor blockade improves the initial ovalbumin-induced arterial hypotension but decreases the survival time in brown norway rats anaphylactic shock. Shock 2003, 19:71-78.
45. Lafforgue E., Sleth J.C., Pluskwa F., Saizy C. Successful extracorporeal resuscitation of a probable perioperative anaphylactic shock due to atracurium. Ann Fr Anesth Reanim 2005, 24:551-555.
46. Del Furia F., Matucci A., Santoro G.M. Anaphylaxis-induced acute ST-segment elevation myocardial ischemia treated with primary percutaneous coronary intervention: report of two cases. J Invasive Cardiol 2008, 20:E73-E76.
47. Levy J.H. Anaphylactic emergencies. Semin Anesth 1998, 17:93-98.
48. Kohno S., Nakao S., Ogawa K., Yamamura H., Nabe T., Ohata K. Possible participation of histamine H3-receptors in the regulation of anaphylactic histamine release from isolated rat peritoneal mast cells. Jpn J Pharmacol 1994, 66:173-180.
49. Hussain A.M., Yousuf B., Khan M.A., Khan F.H., Khan F.A. Vasopressin for the management of catecholamine-resistant anaphylactic shock. Singapore Med J 2008, 49:e225-e228.
50. Meng L., Williams E.L. Case report: treatment of rocuronium-induced anaphylactic shock with vasopressin. Can J Anaesth 2008, 55:437-440.
51. Mayumi H., Kimura S., Asano M., Shimokawa T., Au-Yong T.F., Yayama T. Intravenous cimetidine as an effective treatment for systemic anaphylaxis and acute allergic skin reactions. Ann Allergy 1987, 58:447-450.
52. Schummer W., Schummer C., Wippermann J., Fuchs J. Anaphylactic shock: is vasopressin the drug of choice?. Anesthesiology 2004, 101:1025-1027.
53. Kill C., Wranze E., Wulf H. Successful treatment of severe anaphylactic shock with vasopressin. Two case reports. Int Arch Allergy Immunol 2004, 134:260-261.
54. Whalen J.P. Hypersensitivity to cimetidine. J Clin Pharmacol 1985, 25:610.
55. Hopper J.M., Carter S.R. Anaphylaxis after intra-articular injection of bupivacaine and methylprednisolone. J Bone Joint Surg Br 1993, 75:505-506.